HR Thought Leader Josh Bersin Joins Virgin Pulse CEO Advisory Board

PROVIDENCE, R.I., Jan. 08, 2019 (GLOBE NEWSWIRE) — Virgin Pulse, the largest global employee health and wellbeing company, today announced that renowned HR technology analyst and influencer Josh Bersin, has joined Virgin Pulse’s CEO Advisory Board. In this capacity, Bersin will collaborate with Virgin Pulse CEO, David Osborne, and senior Virgin Pulse leaders to expand awareness […]

Read more

DoubleVerify Partners with MoPub to Combat Mobile Ad Fraud

Partnership extends DV fraud coverage across MoPub’s mobile app exchange NEW YORK, Jan. 08, 2019 (GLOBE NEWSWIRE) — DoubleVerify (“DV”), the leading independent provider of marketing measurement software and analytics, today announced a partnership with MoPub, a leading provider of monetization solutions for mobile app publishers and developers around the globe. As part of the […]

Read more

Quantenna’s Spartan Architecture Brings High-Capacity Mesh Wi-Fi to TIME’s Malaysian Customers

LAS VEGAS, Jan. 08, 2019 (GLOBE NEWSWIRE) — Quantenna Communications, Inc. (NASDAQ : QTNA) announced today that Quantenna’s QV860 chipset is powering TIME dotCom’s latest dual-band dual concurrent mesh extender, the WiFi Booster. Based on the AirTies Air 4830, the WiFi Booster leverages the high-performance capabilities of Spartan architecture to bring extended coverage, increased capacity […]

Read more

LeddarTech Joins Baidu’s Apollo Autonomous Driving Open Platform

LeddarTech joins Baidu’s Apollo autonomous driving open platform with its LiDAR products through an open source SDK QUEBEC CITY, Jan. 08, 2019 (GLOBE NEWSWIRE) — LeddarTech, an industry leader providing the most versatile and scalable auto and mobility LiDAR platform, announced the integration of LeddarTech’s LiDAR products into Apollo, Baidu’s autonomous driving open platform. LeddarTech’s […]

Read more

Lupin Limited: Orphan Drug NaMuscla® Receives European Commission Approval for the Treatment of Myotonia in Non-Dystrophic Myotonic Disorders

Orphan Drug NaMuscla® Receives European Commission Approval for the Treatment of Myotonia in Non-Dystrophic Myotonic Disorders Zug, Switzerland, 8 January 2019: Lupin is pleased to announce that the European Commission (EC) has approved NaMuscla® (mexiletine) for the symptomatic treatment of myotonia in adults with non-dystrophic myotonic (NDM) disorders. Non-dystrophic myotonic disorders are a group of […]

Read more

Nanobiotix and MD Anderson Cancer Center announce a large-scale, comprehensive clinical collaboration on NBTXR3

Collaboration will initially support nine new phase I/II clinical trials with Nanobiotix’s first-in-class agent NBTXR3 for use in treating six cancer types – head and neck, pancreatic, thoracic, lung, gastrointestinal and genitourinary cancers – involving around 340 patients Most of the trials are expected to be launched in 2019 Collaboration includes a $12M total investment […]

Read more